1 Raju TN, Nelson KB, Ferriero D, et al. Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke[J]. Pediatrics, 2007, 120(3): 609-616.
[2]
2 Lynch JK. Epidemiology and classification of perinatal stroke[J]. Semin Fetal Neonatal Med, 2009, 14(5): 245-249.
[3]
3 Lee J, Croen LA, Backstrand KH, et al. Maternal and infant characteristics associated with perinatal arterial stroke in the infant[J]. JAMA, 2005, 293(6): 723-729.
6 Renaud C, Bonneau C, Presles E, et al. Lipoprotein (a), birth weight and neonatal stroke[J]. Neonatology, 2010, 98(3): 225-228.
[7]
7 Krause M, Sonntag B, Klamroth R, et al. Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage: results of a multicentre case-control study[J]. Thromb Haemost, 2005, 93(5): 867-871.
15 Gawish GE. Molecular characterization of factor V leiden G1691A and prothrombin G20210A mutations in saudi newborns with stroke[J]. Biochem Genet, 2011, 49(9/10): 601-610.
[16]
16 Mallick AA, O’callaghan FJ. The epidemiology of childhood stroke[J]. Eur J Paediatr Neurol, 2010, 14(3): 197-205.
[17]
17 Du LN, Bayir H, Lai YC, et al. Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway[J]. J Biol Chem, 2004, 279(37): 38563-38570.
[18]
18 Maingay-De GF, Lequin MH, Roofthooft DW, et al. Extensive cerebral infarctio in the newborn due to incontinentia pigmenti[J]. Eur J Paediatr Neurol, 2008, 12(4): 284-289.
21 Badve CA, Khanna PC, Ishak GE. Neonatal ischemic brain injury: what every radiologist needs to know[J]. Pediatr Radiol, 2012, 42(5): 606-619.
[22]
22 Kuker W, Mohrle S, Mader I, et al. MRI for the management of neonatal cerebral infarctions: importance of timing[J]. Childs NervSyst, 2004, 20(10): 742-748.
24 Jordan LC, Rafay MF, Smith SE, et al. Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the international pediatric stroke study[J]. J Pediatrics, 2010, 156(5): U43-U704.
[25]
25 Lebas A, Chabrier S, Fluss J, et al. EPNS/SFNP guideline on the anticoagulant treatment of cerebral sinovenous thrombosis in children and neonates[J]. Eur J Paediatr Neurol, 2012, 16(3): 219-228.
[26]
26 Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young[J]. Stroke, 2008, 39(9): 2644-2691.
[27]
27 Amlie-Lefond C, Deveber G, Chan AK, et al. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study[J]. Lancet Neurol, 2009, 8(6): 530-536.
[28]
28 Wasay M, Dai AI, Ansari M, et al. Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States[J]. J Child Neurol, 2008, 23(1): 26-31.
[29]
29 Jenkins DD, Lee T, Chiuzan C, et al. Altered circulating leukocytes and their chemokines in a clinical trial of therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy[J]. Pediatr Crit Care Med, 2013, 14(8): 786-795.
[30]
30 Klehmet J, Harms H, Richter M, et al. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial[J]. Neuroscience, 2009, 158(3): 1184-1193.
[31]
31 Velthoven CT, Sheldon RA, Kavelaars A, et al. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke[J]. Stroke, 2013, 44(5): 1426-1432.
33 Doycheva D, Shih G, Chen H, et al. Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a olitary treatment[J]. Transl Stroke Res, 2013, 4(2): 171-178.
[34]
34 Solaroglu I, Tsubokawa T, Cahill J, et al. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat[J]. Neuroscience, 2006, 143(4): 965-974.
[35]
35 Kaneko Y, Tajiri N, Su TP, et al. Combination treatment of hypothermia and mesenchymal stromal cells amplifies neuroprotection in primary rat neurons exposed to hypoxic-ischemic-like injury in vitro: role of the opioid system[J]. PLoS One, 2012, 7(10): e47583.
[36]
36 Tsai SY, Lee CT, Hayashi T, et al. Delta opioid peptide DADLE and naltrexone cause cell cycle arrest and differentiation in a CNS neural progenitor cell line[J]. Synapse, 2010, 64(4): 267-273.
